Mechanistic comparison of bardoxolone and alyssin [Supplementary Concept] based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
18%
Jaccard Similarity
21%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
bardoxolone and alyssin share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.182 means 18% of the combined target set is bound by both compounds. The IDF-weighted score of 0.208 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do bardoxolone and alyssin have in common?
bardoxolone and alyssin share 2 molecular targets with a Jaccard similarity of 18%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can bardoxolone and alyssin be combined?
bardoxolone and alyssin share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: bardoxolone or alyssin?
In the BiohacksAI corpus: bardoxolone has 0 PubMed-indexed studies, alyssin has 300 studies.